(Press-News.org) The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide. Researchers working under the auspices of Prof. Christoph Maier (Director of the Pain Clinic Bergmannsheil at the Ruhr University in Bochum) presume that ziconotide not only suppresses the transmission of pain stimuli, but also deteriorates the frame of mind and could simultaneously reduce anxiety and impulse control. These mechanisms could promote suicidal tendencies in vulnerable patients. The research scientists thus advise careful diagnosis and monitoring of the psychic condition of patients treated with ziconotide. They have published their findings in the Medical Journal Pain.
Alternative to opioids for severe pain
Ziconotide has numerous advantages, including the fact that it does not have any of the side effects typically associated with opioids, such as respiratory depression (asphyxia). Moreover, it does not lead to tolerance development. It has been on the European and American market since 2004, being administered to patients with intrathecal pumps if opioids do not suffice or if these trigger inacceptable side effects. Recently, the number of reports on the psychic side effects of ziconotide has increased. The researchers in Bochum analysed numerous studies, registering an increasing number of attempted suicides, which the original authors had not attributed to the ziconotide treatment. In PAIN, the physicians from RUB present two new cases, which underscore the suspicion that ziconotide enhances suicidal ideation.
Suicide despite pain relief and normal test results
As Prof. Maier stated, the first case is particularly tragic, the patient concerned, who had had pain is his feet for many years and undergone numerous unsuccessful treatments, having experienced a distinct improvement and pain relief for the first time when treated with ziconotide. There were no side effects. Tests disclosed that his depressiveness, which had also not been particularly marked before the ziconotide treatment commenced, even decreased. After a good three weeks, he appeared to be happy to all concerned. But two months after the ziconotide treatment had commenced he unexpectedly committed suicide. A further patient, a 39-year-old woman, who had undergone pain treatment for backache for 14 years, had had depressive phases 20 years previously and had attempted suicide after a pregnancy. Two months after the ziconotide treatment had commenced – which, according to current recommendations, should never have been administered to her in the first place due to her medical history – she mentioned that she had increased suicidal ideation. Moreover, she complained of other psychic side effects with hallucinations, confusion and partial amnesia, which had resulted in two severe car accidents. It is conceivable that the accidents were also of suicidal character. The physicians stopped the ziconotide treatment. Two weeks later both the suicidal ideation and the hallucinations were history.
Pharmaceutical companies and approval authorities must investigate the situation
Prof. Maier concludes that both cases underscore the assumption that there is a causality between ziconotide and suicidal tendencies. The pain specialist strongly emphasizes that the pharmaceutical companies and approval authorities should urgently investigate this yet again. All patients must be analysed for possible psychic disorders before treatment commences and closely monitored irrespective of pain relief due to the drug. The above-mentioned cases also underscore the fact that an increase in pain treatment when standard drugs fail is not always the correct mode of action. As Prof. Maier so aptly said, it is often even exactly the wrong path. This had already been pointed out a few weeks previously at the Congress of the German Pain Therapists (Kongress der deutschen Schmerztherapeuten)
INFORMATION:
Title
Christoph Maier, Hans-Helmut Gockel, Kai Gruhn, Elena K. Krumova and Marc-Andreas Edel: Increased risk of suicide under intrathecal ziconotide treatment? – A warning. In: Pain, online 1.11.2010, doi:10.1016/j.pain.2010.10.007, http://www.painjournalonline.com/article/S0304-3959%2810%2900615-9/abstract
Further Information
Prof. Dr. Christoph Maier, Leiter der Schmerzklinik des RUB-Klinikums Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Tel. +49(0)234/302-6366, E-Mail: christoph.maier@rub.de
Editor: Meike Drießen
END
Montreal, November 23, 2010 – Pathological gamblers are risking more than their money, they are also three times more likely to commit suicide than non-betters. A new Montreal inter-university study has shown these gamblers are also plagued by personality disorders. These findings, published in a recent issue of the Psychology of Addictive Behaviors, may have implications for developing improved targeted suicide prevention programs.
"The World Health Organization estimates that suicide is one of the top ten causes of death in the Western world," says study co-author, ...
Working at a crossroad between biology and engineering, scientists have modeled and are now mimicking the ingenious natural design of falling geckoes, gliding snakes, cruising seagulls, flapping insects and floating maple seeds to improve the design of air vehicles.
IOP Publishing's Bioinspiration & Biomimetics publishes a special edition today, Wednesday 24 November 2010, entitled Bioinspired Flight, comprising of nine journal papers which display the wealth of knowledge being accrued by researchers in the field.
Nature outclasses man's best efforts at robotic flight, ...
Southampton scientists along with colleagues in New Zealand have used a sophisticated optical mapping technique to identify and accurately measure changes in coastal morphology following a catastrophic series of landslides.
"Our findings are important for assessing geological hazards and reducing the dangers to human settlements," said geophysicist Professor Jon Bull of the University of Southampton's School of Ocean and Earth Science based at the National Oceanography Centre, Southampton,
Matata is a small coastal town located on the Bay of Plenty at the northern end ...
A new study determined that African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA). RA risk is more pronounced among individuals positive for the HLA-DRB1 shared epitope, a genetic risk factor for RA. Findings from this study—the largest to date examining the impact of smoking on RA risk in an African American population—are available in the December issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
RA is a chronic inflammatory disease that affects ...
Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA symptoms appear are more likely to experience less joint destruction and improved chances of DMARD-free disease remission. Details of this novel study are published in the December issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
The World Health Organization (WHO) estimates ...
Scientists at The University of Nottingham have made a major breakthrough that could help shape the future of nanotechnology, by demonstrating for the first time that 3-D molecular structures can be built on a surface.
The discovery could prove a significant step forward towards the development of new nano devices such as cutting-edge optical and electronic technologies and even molecular computers.
In a paper published in the prestigious journal Nature Chemistry, the team of chemists and physicists at Nottingham have shown that by introducing a 'guest' molecule they ...
A team of Australian researchers involving DNA experts from the University of Adelaide has identified a new, critically endangered species of ground parrot in Western Australia.
The team, led by Australian Wildlife Conservancy's Dr Stephen Murphy, used DNA from museum specimens up to 160 years old to reveal that populations of ground parrots in eastern and western Australia are highly distinct from each other and that the western populations should be recognized as a new species, Pezoporus flaviventris.
"The discovery has major conservation implications," said Dr Murphy. ...
Putting tobacco out of sight in shops can change the attitude of young people to smoking, while not hitting retailers in the pocket, researchers at The University of Nottingham have discovered.
Academics from the University's UK Centre for Tobacco Control Studies looked at the effect of the removal of tobacco displays in the Republic of Ireland, ahead of similar legislation which is due to come into force in the UK. The findings are published today in the journal Tobacco Control.
In one study the research team found that the number of teenagers who recalled tobacco ...
St. Louis, MO, 23 November, 2010 – Proper nutrition therapy is essential for the successful management of type 1 and type 2 diabetes and registered dietitians (RDs) can play a key role as part of the health care team. An article in the December issue of the Journal of the American Dietetic Association reviews the evidence and nutrition practice recommendations presented in the American Dietetic Association Nutrition Practice Guidelines for Type 1 and Type 2 Diabetes in Adults. This complete and systematic review presents 29 key nutrition practice guidelines in order to ...
A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV prevention research, come from a large international clinical trial published online Nov. 23 by the New England Journal of Medicine. The study, titled "Chemoprophylaxis for HIV Prevention in Men," found even higher rates of effectiveness, up to 72.8 percent, among those participants who adhered most closely to the daily drug regimen.
"We now have strong ...
